The IDEA project, initiated over a decade ago with support of, and supervision by, the European Commission and its scientific advisors focuses on building a framework to managing fragrance allergens effectively. It aims to arrive at improved tools via a multistakeholder dialogue. A key element is establish reliable clinical data via a network of trusted European clinics for evaluation of the performance of risk assessment tools and derived policy.
In 2022, a pilot project determined adequate test concentrations for 5 so far not routinely patch tested fragrance ingredient and tested the data collection system, expanding in 2023 with the recruitment of new clinics By 2024, broader testing is planned to assess IFRA Standards' potential impact on reducing fragrance allergies, aiding in policy refinement. Challenges include securing long-term funding and maintaining trust with clinical partners.
Find out more about the IDEA project by visiting: https://ideaproject.info/
